Know When to Offer COVID-19 Post-Exposure Prophylaxis
You’ll hear buzz about Regen-COV (casirivimab/imdevimab), the first med to PREVENT COVID-19...especially with cases on the rise.
This injectable monoclonal antibody combo blocks SARS-CoV-2 from entering cells.
It’s already authorized to TREAT mild to moderate COVID-19 in outpatients age 12 or older at high risk of severe illness. This includes patients with diabetes...age 65 or older...or even with a BMI over 25.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: PA includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote